Catecholamines, opioids, and vagal afferents in the nucleus of the solitary tract.
Pickel
V M
VM
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
Aicher
S A
SA
Aoki
C
C
Cheng
P Y
PY
Nirenberg
M J
MJ
D000344:Afferent Pathways / Q000166:cytology / Q000502:physiology*; D000818:Animals; D008562:Membrane Glycoproteins / Q000032:analysis; D026901:Membrane Transport Proteins; D009457:Neuroglia / Q000166:cytology / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000502:physiology; D009479:Neuropeptides; D051381:Rats; D017207:Rats, Sprague-Dawley; D011943:Receptors, Adrenergic, beta / Q000032:analysis*; D017450:Receptors, Opioid, mu / Q000032:analysis*; D017552:Solitary Nucleus / Q000166:cytology / Q000502:physiology*; D013572:Synaptic Vesicles / Q000502:physiology / Q000648:ultrastructure; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis; D014630:Vagus Nerve / Q000166:cytology / Q000502:physiology*; D050492:Vesicular Biogenic Amine Transport Proteins
D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009479:Neuropeptides; D011943:Receptors, Adrenergic, beta; D017450:Receptors, Opioid, mu; D050492:Vesicular Biogenic Amine Transport Proteins; D014446:Tyrosine 3-Monooxygenase